Pharmaceutical News

RSS

Timing of FDA Plan B announcement questioned

The Center for Reproductive Rights issued the following statement from Nancy Northup, president of the Center for Reproductive Rights, in response to the FDA announcement regarding Plan B.

2 Aug 2006

FDA approves Keppra (levetiracetam) for epilepsy treatment

UCB has announced that the U.S. Food and Drug Administration (FDA) has approved Keppra (levetiracetam) injection for use as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy.

2 Aug 2006

Doctors say HPV vaccine should be given to everyone

A new vaccine which will protect women against four types of the human papillomavirus (HPV) known to cause cervical cancer will be available within weeks in the UK.

31 Jul 2006

FDA does an about turn on Plan B contraceptive pills

After years of dilly dallying over it's stand on over-the-counter sales of the "morning-after" contraceptive officials at the U.S. Food and Drug Administration (FDA) suddenly appear to be doing an about turn.

31 Jul 2006

Smart cancer drug on sale in the UK

A new "smart" cancer drug will be available to patients in Britain today which works by deploying two chemical 'bullets' that attack specific molecular targets, starving tumours of nutrients and inhibiting the enzyme that signals cells to multiply.

31 Jul 2006

HHS to stockpile Anthrax immune globulin

The Department of Health and Human Services (HHS) has announced it will purchase 10,000 therapeutic courses of treatment of Anthrax Immune Globulin (AIG) from Cangene Corporation of Winnipeg, Manitoba, Canada for a total of $143,833,719.

30 Jul 2006

FDA warns against use of high-strength hydrogen peroxide to treat serious diseases

The Food and Drug Administration in the U.S. has issued a warning against drinking or injecting high-strength hydrogen peroxide products to treat serious diseases such as AIDS.

30 Jul 2006

New sunscreen protects against both UVA and UVB rays

People will now be able to get better protection from the sun with a new sunscreen recently approved by the U.S. Food and Drug Administration (FDA).

27 Jul 2006

New bird flu vaccine has 80% protection rate

According to the manufacturer the latest bird flu vaccine is more than 80% effective in protecting people against the virus.

26 Jul 2006

Remicade receives European approval for treatment of psoriatic arthritis

Schering-Plough Corporation today announced that the European Commission has approved the use of Remicade (infliximab) as monotherapy in the treatment of active and progressive psoriatic arthritis (PsA) in patients who show intolerance to methotrexate or for whom methotrexate is contraindicated.

26 Jul 2006

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

NICE has today issued guidance for the use of the targeted biological therapies, Enbrel (etanercept) and Raptiva (efalizumab), to treat adult patients with severe plaque psoriasis.

26 Jul 2006

GSK reports significant advance in H5N1 pandemic flu vaccine programme

GlaxoSmithKline (GSK) today announced headline data showing that its H5N1 pandemic flu vaccine achieved a high immune response at a low dose of antigen.

26 Jul 2006

New OTC sunscreen product approved by FDA

FDA has approved Anthelios SX, a sunscreen from L'Oreal to be sold over-the-counter (OTC) for the prevention of sunburn and for protection against ultraviolet B (UVB) and ultraviolet A (UVA) rays.

25 Jul 2006

FDA approves Elaprase (idursulfase) for Hunter syndrome

The U.S. Food and Drug Administration (FDA) has approved Elaprase (idursulfase), the first product for the treatment of Hunter syndrome (Mucopolysaccharidosis II, or MPS II).

25 Jul 2006

FDA expands use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) has expanded the approved use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia (ALL) as part of a multiple drug chemotherapy regimen.

25 Jul 2006

Nexavar approved in Europe for treatment of advanced kidney cancer

Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc have announced that the European Commission has granted marketing authorization to Nexavar (sorafenib) tablets for the treatment of patients with advanced renal cell carcinoma.

24 Jul 2006

FDA warns against use of "bismacine," also known as chromocine

The U.S. Food & Drug Administration (FDA) is warning consumers and health care providers not to use a product called "bismacine," also known as chromocine.

21 Jul 2006

New 'patch' drug therapy for Alzheimer's has fewer side effects

Alzheimer's, is the most common form of dementia and affects as many as 15 million people worldwide.

20 Jul 2006

New guidelines for antiepileptic drugs

The International League Against Epilepsy has set new treatment guidelines for antiepileptic drugs, as published in the journal Epilepsia.

19 Jul 2006

Ranbaxy to acquire the Mundogen generic business from GlaxoSmithKline

Ranbaxy, India's largest pharmaceutical company, and among the top ten generic pharmaceutical companies in the world, announced today that the Company has acquired the Mundogen generic business of GlaxoSmithKline.

19 Jul 2006